There are many good reasons for your organisation to completely or partially outsource research on a contract basis, i.e., contract research. Collaborating with the Amsterdam research landscape not only saves time and reduces costs, your company will also benefit enormously by gaining access to specialised knowledge or expertise, and cutting-edge facilities. For instance:
Continue reading after the photo.
Successful collaborations start with good agreements. In contract research and contract manufacturing, you determine together with the researcher what is to be expected in terms of output (data, materials, inventories, reports etc.) and standards (quality standards etc.). Besides discussing which joint efforts are needed to deliver the required outcomes, financial and legal matters have to be tackled, such as fees, intellectual property rights and ownership on application.
IXA’s legal experts and business developers provide support and advice in the negotiations and in drafting public-private partnership contracts. These contracts will be fine-tuned to the particular nature of the activities and the needs and interests of the parties involved.
The ACE Incubation Program kicked off with six innovative tech and science based startups of VU, UvA, HvA and other universities. In this 10 week program the startups will get intensive training after which they are ready to spread their wings. Meet the startups: DBugIT – VU Startup Sector: Software Founders: Marc Went, Robert Jansma, […]
NewsAt the start of 2022, Amsterdam Public Health (APH) in collaboration with IXA have launched a call for support of valorisation and impact projects within the research institute. This resulted in 23 interesting applications, of which three projects have been awarded a grant of € 2500.- complemented with in-kind support from Innovation Exchange Amsterdam (IXA). […]
NewsDog Rax had bone cancer, was given a cancer vaccine at the Medical Center for Animals, and seems to be all right. It is hopeful news in the development of a cancer vaccine for humans, says Arjan Griffioen, professor of Experimental Oncology at Amsterdam UMC . He has been working on the development of this […]
News